News & Articles

SciLifeLab and UCL team use in situ sequencing to produce first spatial map of closely related brain tissue cells

Dr. Chris Vakulskas talks about the work he is doing with CRISPR, the challenges involved and new innovations within the field

Adakveo targets key molecule for the prevention of sickle cell pathology

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system

The eCHO™ Medium is ideal for the manufacture of recombinant proteins for medical use, including monoclonal antibodies and complex glycoproteins

Learn how Bio-Rad has continually responded to researchers’ needs to drive innovation in its genomics technologies over the past 30 years

Sartorius Intellicyt addresses challenges such as high cost and purification difficulties and presents possible solutions

Addressing the challenges of daily food quality control inspections

Multiplexed immunofluorescence and next-generation image analysis offer spatial insights into the tumor microenvironment

Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago

Newly discovered antibodies promise significant improvement over current therapies

Thermo Fisher Scientific Orbitrap GC-MS technology to be integrated into Breath Biopsy to support identification of novel biomarkers for early disease detection

Paragon Genomics announced the two products at the 2019 Association for Molecular Pathology (AMP)

Dr. Angela Smirnova discusses her work on microbial ecology, including how the concept of ‘bioremediation’ could help to tackle greenhouse gas emissions with microbes

Watch this webinar to find out how to automate your NGS workflow for cancer diagnostics and personalized medicine

Envigo enters CRISPR gene-edited research model field with the addition of Horizon’s business

The technology allows for the placement of unnatural amino acids into recombinant antibodies at specific sites

Discover how RNA in situ hybridization assays are being used to advance research into treatments for Achilles tendon injuries

The Sentosa® SQ HIV-1 Genotyping Assay is the first FDA De Novo-designated NGS assay for detecting HIV-1 drug resistance mutations

Technology brings University scientists unparalleled potential for chemical, biological and human disease research